Ranbaxy Laboratories Ltd :

354.15 1.75 [0.50%]

ISIN: INE015A01028 | NSE: RANBAXY | Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: 500359 | Comments

Price Information
• Open	352.90
• High	359.35
• Low	349.00
• Previous Close	352.40
• Shares Traded	352028
• 52 Wk High Price	578.30
• 52 Wk High Date	04-09-2012
• 52 Wk Low Price	342.75
• 52 Wk Low Date	18-06-2013
• Face Value	5.00

Fundamentals
• Market Capital (Rs.cr)	15460.10
• EPS (Rs.)(TTM)	-
• P/E Ratio(TTM)	-
• Book Value (Rs.)	45.40
• Price to Book Value	8.04
• Equity (Rs.cr.)	211.55
• Traded Value (Rs.lac)	565.08

Corporate Actions
Ex-Date	Purpose (Rs.)
2011-04-28	40% Dividend (2)

Index Names
• BSE-100
• BSE-200
• BSE-500
• BSE HC
• S&P CNX Nifty

Related Companies
Stock Name	Price

CIPLA	379.85
JBCHEPHARM	78.90
JAYANTVITAMINS	3.00	-
MERIND	200.00	-
PIRHEALTH	557.20
UNICHEMLAB	166.75
ALEMBICLTD	19.60
LYKALABS	10.46
TTKHEALTH	542.45
DRREDDY	2099.50

Share Tips for Ranbaxy Laboratories Ltd

Intraday trading calls : Weak on early (09:10AM, Jun 19 '13)

sell ranbaxy : sell Ranbaxy 353 tgt 342 (07:54AM, Jun 19 '13)

TOMORROW TRADING CALLS AND TIPS BY THE (05:50PM, Jun 18 '13)

Sell call : Sell ranbaxy below 349 sl 3 (11:50AM, Jun 18 '13)

Share Tips: RANBAXY Selling Zone !!! S (10:21AM, Jun 18 '13)

Mutual funds holding in Ranbaxy Laboratories Ltd

Reliance Diversified Power Sector Fund - Growth

Reliance Banking Fund - Growth

Sundaram BNP Paribas Taxsaver - (Open Ended Fund) - Growth

Baroda Pioneer Growth Fund - Growth

Sahara Growth Fund - Growth

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Mar, 2013	Mar, 2013	Dec, 2012
• Sales (Rs.cr)	1327.88	5821.20	6303.55
• Net Profit (Rs.cr)	-11.69	-277.64	216.56
• Net Profit Var (%)	-	-	-69.00
• EPS (Rs)	-	-	5.10
• P/E Ratio	-	-	71.60
• Operating Profit Margin	-	-0.34	-
• CPS (Rs.)	-	-	9.50
• P/C Ratio	-	-	38.40
• Div%	-	-	-

Announcements
19-04-2012	Daiichi Sankyo and Ranbaxy to expand hybrid business model in Romania
21-12-2011	Ranbaxy announces consent decree with U.S. Food and Drug Administration
28-05-2012	Ranbaxy announces USFDA approval of Cip-Isotretinoin NDA
06-03-2012	Ranbaxy becomes the first company to launch generic Atorvastatin in Italy, Netherlands & Sweden
12-07-2011	Ranbaxy enters into a licensing agreement with Gilead Sciences
12-01-2011	Ranbaxy Laboratories allots equity shares
09-05-2012	Ranbaxy Laboratories appoints additional director
25-08-2011	Ranbaxy Laboratories appoints president & CFO
23-01-2012	Ranbaxy Laboratories gets UK MHRA nod for generic Singulair tablets
24-11-2012	Ranbaxy Laboratories issues redeemable non-convertible debentures
22-02-2011	Ranbaxy Laboratories recommends dividend
31-01-2012	Ranbaxy Laboratories to announce financial results
10-04-2013	Ranbaxy Laboratories to announce Q1 results
10-10-2011	Ranbaxy Laboratories to announce Q3 results
15-02-2011	Ranbaxy Laboratories to consider dividend
07-05-2013	Ranbaxy Laboratories to Convene AGM
26-11-2012	Ranbaxy launches Absorica (Isotretinoin) Capsules in US Healthcare Market
18-08-2012	Ranbaxy launches authorized generic of Pioglitazone in US
07-12-2011	Ranbaxy launches authorized generic version of caduet in the US
26-07-2011	Ranbaxy launches Letrozole tablets in UK, Romania & France
31-03-2012	Ranbaxy receives approval to Market RAN - ROSUVASTATIN in Canada
05-09-2011	Ranbaxy UK launches esomeprazole

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

18-06-2013 127131 770102 16.51 44800964 271177.00
17-06-2013 60051 153498 39.12 21942635 56507.50
13-06-2013 32463 141761 22.90 12136293 53754.80
07-06-2013 30288 154154 19.65 11429177 58259.00
28-05-2013 31502 257154 12.25 12460616 102716.00

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Ranbaxy Laboratories Ltd

Hot Searches • grad • tatamoto • hilt • balm • live • lupin • rpower • icsa • advanta • mindtree

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
18-06-2013	127131	770102	16.51	44800964	271177.00
17-06-2013	60051	153498	39.12	21942635	56507.50
13-06-2013	32463	141761	22.90	12136293	53754.80
07-06-2013	30288	154154	19.65	11429177	58259.00
28-05-2013	31502	257154	12.25	12460616	102716.00